Showing results (1-10 of 262) with videos related to
Sort By:
Pageof 27
Therapeutic Innovation & Regulatory Science|January 9, 2024
Quantifying Site Burden to Optimize Protocol PerformanceMaria Florez, Zachary Smith, Zachary Olah, et al.Therapeutic Innovation & Regulatory Science|May 11, 2024
Examining the Association Between DCT Solutions Use and Participant Diversity in Clinical TrialsZachary Smith, Kenneth GetzTherapeutic Innovation & Regulatory Science|December 1, 2023
A Case Study Assessment on the Rationale for, and Relevance of, Non-Core Protocol DataZachary Smith, Kenneth GetzTherapeutic Innovation & Regulatory Science|June 10, 2022
Quantifying Diversity and Representation in Pivotal Trials Leading to Marketing Authorization in EuropeZachary Smith, Emily Botto, Kenneth GetzTherapeutic Innovation & Regulatory Science|August 12, 2022
Protocol Design and Performance Benchmarks by Phase and by Oncology and Rare Disease SubgroupsKenneth Getz, Zachary Smith, Marcy KravetTherapeutic Innovation & Regulatory Science|March 26, 2024
New Benchmarks on Protocol Amendment Experience in Oncology Clinical TrialsEmily Botto, Zachary Smith, Kenneth GetzTherapeutic Innovation & Regulatory Science|January 30, 2022
Protocol Design Variables Highly Correlated with, and Predictive of, Clinical Trial PerformanceZachary Smith, Ralf Bilke, Sybrand Pretorius, et al.Therapeutic Innovation & Regulatory Science|April 5, 2022
Benchmarking Protocol Deviations and Their Variation by Major Disease CategoriesKenneth Getz, Zachary Smith, Ananya Jain, et al.Therapeutic Innovation & Regulatory Science|December 1, 2020
Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical TrialsKenneth Getz, Zachary Smith, Laura Shafner, et al.Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.Pageof 27